These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 266841

  • 21. Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis.
    Heurkens AH, Westedt ML, Breedveld FC.
    Arch Intern Med; 1991 Nov; 151(11):2249-54. PubMed ID: 1953230
    [Abstract] [Full Text] [Related]

  • 22. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA, McCune WJ.
    Concepts Immunopathol; 1989 Nov; 7():20-78. PubMed ID: 2676180
    [No Abstract] [Full Text] [Related]

  • 23. [Immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H.
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):215-7. PubMed ID: 4538326
    [No Abstract] [Full Text] [Related]

  • 24. Azathioprine in connective tissue disorders.
    Br Med J; 1972 Mar 11; 1(5801):645-6. PubMed ID: 5015288
    [No Abstract] [Full Text] [Related]

  • 25. [Preliminary report on experience with immunosuppressive therapy in progressive chronic (rheumatoid) polyarthritis and collagen diseases].
    Schuster F, Beier A, Eberl R, Tausch G.
    Z Rheumaforsch; 1969 Mar 11; 28(1):12-20. PubMed ID: 5810410
    [No Abstract] [Full Text] [Related]

  • 26. [Current problems of immunology and immunosuppressive therapy in rheumatic diseases].
    Vorlaender KO.
    Clin Ter; 1967 Jul 15; 42(1):3-14. PubMed ID: 4386113
    [No Abstract] [Full Text] [Related]

  • 27. [Drug therapy in collagen diseases].
    Brühl W.
    Wiad Lek; 1971 Jul 01; 24(13):1279-83. PubMed ID: 4256585
    [No Abstract] [Full Text] [Related]

  • 28. [Immunosuppressive treatment in rheumatology].
    Menkes CJ.
    Cah Med; 1971 Dec 15; 12(16):1391-8. PubMed ID: 5316944
    [No Abstract] [Full Text] [Related]

  • 29. [Infections and immunosuppressive agents in rheumatology].
    Kahn MF, Vitale C, Grimaldi A.
    Sem Hop; 1971 Dec 15; 52(22-23):1374-6. PubMed ID: 183273
    [Abstract] [Full Text] [Related]

  • 30. [Differential indications in rheumatism therapy on the basis of well-known drug side effects].
    Mathies H.
    Acta Med Austriaca; 1975 Dec 15; 2(4):156-60. PubMed ID: 1224932
    [Abstract] [Full Text] [Related]

  • 31. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV, Holley KE, Ilstrup DM.
    Am J Kidney Dis; 1982 Jul 15; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [Abstract] [Full Text] [Related]

  • 32. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.
    Khalidi NA, Rebello R, Robertson DD.
    J Laryngol Otol; 2008 Dec 15; 122(12):1371-6. PubMed ID: 18282337
    [Abstract] [Full Text] [Related]

  • 33. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE.
    Ann Rheum Dis; 2008 Jan 15; 67(1):74-9. PubMed ID: 17545189
    [Abstract] [Full Text] [Related]

  • 34. Severe disease activity and complications of immunosuppressive therapy: a challenge for acute hospital-based rehabilitation in rheumatology.
    Kujath K, Hermann KG, Mathiske-Schmidt K, Schwedtke C, Hiepe F, Burmester GR, Reisshauer A.
    J Rheumatol; 2009 Aug 15; 36(8):1618-25. PubMed ID: 19531761
    [Abstract] [Full Text] [Related]

  • 35. Treatment of collagen diseases with cytostatics.
    Lorenzen I, Videbaek A.
    Lancet; 1965 Sep 18; 2(7412):558-61. PubMed ID: 4158189
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
    Michel M, Habibi A, Godeau B, Bachir D, Lahary A, Galacteros F, Fifi-Mah A, Arfi S.
    Semin Arthritis Rheum; 2008 Dec 18; 38(3):228-40. PubMed ID: 18177923
    [Abstract] [Full Text] [Related]

  • 37. Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy.
    Sharon E, Kaplan D, Diamond HS.
    N Engl J Med; 1973 Jan 18; 288(3):122-4. PubMed ID: 4564983
    [No Abstract] [Full Text] [Related]

  • 38. The treatment of connective tissue diseases with antilymphocyte globulin.
    Denman AM, Pelton BK, Kinsley M, Knight S, Partridge C, Walker P, Bannister B, Gumpel M, Smith DS, Loewi E.
    Postgrad Med J; 1976 Jan 18; 52(5 Suppl):118-22. PubMed ID: 995782
    [Abstract] [Full Text] [Related]

  • 39. [Prerequisites and first results of the therapeutic use of azathioprine (imuran) in chronic progressive rheumatic arthritis and in so-called collagen diseases].
    Barnikol HU, Vorlaender KO.
    Med Welt; 1967 Jan 21; 3():160-9. PubMed ID: 4383822
    [No Abstract] [Full Text] [Related]

  • 40. Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans.
    DePinho RA, Goldberg CS, Lefkowitch JH.
    Gastroenterology; 1984 Jan 21; 86(1):162-5. PubMed ID: 6689657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.